Ketan Dhatariya | Professor Ketan Dhatariya

How can point-of-care technologies support in-hospital diabetes care?

by Ketan Dhatariya | Mar 12, 2023 | 2023

Misra S, Avari P, Lumb A, Flanagan D, Choudhary P, Rayman G, Dhatariya K. Journal of Diabetes Science and Technology...

Gaps in our knowledge of managing inpatient dysglycaemia and diabetes in non-critically ill adults: A call for further research.

by Ketan Dhatariya | Feb 12, 2023 | 2023

Dhatariya K, Umpierrez GE. Diabetic Medicine...

Management of Hyperosmolar Hyperglycaemic State (HHS) in Adults: An updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care.

by Ketan Dhatariya | Feb 12, 2023 | 2023

Mustafa OG, Haq M, Dashora U, Castro E, Dhatariya KK, on behalf of the Joint British Diabetes Societies (JBDS) for Inpatient Care. Diabetic Medicine...

Initiation and continuation of sodium-glucose cotransporter 2 inhibitors in hospital inpatients – ready for prime time?

by Ketan Dhatariya | Jan 28, 2023 | Editorials

Dhatariya K. Diabetes Care...

Professor Ketan Dhatariya on the ‘Talking Diabetes’ Podcast

by Ketan Dhatariya | Jan 26, 2023 | Miscellaneous

Professor Ketan Dhatariya was the guest on this episode of the ‘Talking Diabetes’ podcast....

PROFESSOR KETAN DHATARIYA

Consultant in Diabetes, Endocrinology & General Medicine

How can point-of-care technologies support in-hospital diabetes care?

Gaps in our knowledge of managing inpatient dysglycaemia and diabetes in non-critically ill adults: A call for further research.

Management of Hyperosmolar Hyperglycaemic State (HHS) in Adults: An updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care.

Initiation and continuation of sodium-glucose cotransporter 2 inhibitors in hospital inpatients – ready for prime time?

Professor Ketan Dhatariya on the ‘Talking Diabetes’ Podcast

Recent Posts